JDD November Issue Highlights: Lasers, Light Sources, and Devices
116911169111691
The November issue of the Journal of Drugs in Dermatology focuses on the topics of Lasers, Light Sources, and Devices, featuring an outstanding line-up of original articles. Straight from the JDD Editor’s desk, we share this month’s issue highlights
The Guest Editorial by Dr. Macrene Alexiades focuses on the growing body of objective quantifiable data demonstrating time-sensitive improvemen …
The November issue of the Journal of Drugs in Dermatology focuses on the topics of Lasers, Light Sources, and Devices, featuring an outstanding line-up of original articles. Straight from the JDD Editor’s desk, we share this month’s issue highlights
The Guest Editorial by Dr. Macrene Alexiades focuses on the growing body of objective quantifiable data demonstrating time-sensitive improvemen … Continue reading "JDD November Issue Highlights: Lasers, Light Sources, and Devices"
The title of today’s broadcast: Practical Applications of Lasers and Energy-Based Modalities in Skin of Color. That is a mouth-full to basically tell us that we are getting the best tips to treat refractory medical and aesthetically-concerning conditions from 3 of dermatology’s foremost experts in skin of color: Dr. Eliot Battle, Dr. Cheryl Burgess, and Dr. Andrew Alexis.
WOW! We were in fo … 
We kick off Hyperhidrosis Awareness Month with a look at the ABCs of Hyperhidrosis Diagnosis:
There are two types of hyperhidrosis (Hh): primary and secondary.
Secondary Hh is sweating that is caused by or is a symptom of another underlying medical condition or is a side effect of a medication. Ruling out secondary hyperhidrosis (or responding to secondary Hh appropriately) is the first step … 
One of the most vulnerable populations among both teenagers and adults today is the LGBTQ community. An estimate of the LGBTQ population is difficult to solidify, but based on survey data it is estimated that sexual and gender minority individuals collectively represent four percent of the general population. The LGBTQ community is more likely to experience both dysphoria and discrimination, and t … 
When standard treatment options fail and corticosteroids are not a long-term option, dermatologists often have to look back to their tool-kit and pull out the “big guns.” Mycophenolate mofetil has emerged as a promising immunosuppressive agent for severe immune-mediated and inflammatory dermatologic disease. We continue our series, Therapeutic Cheat Sheet, with a closer look at mycophenolate m … 